Michel Geist

653 total citations
19 papers, 447 citations indexed

About

Michel Geist is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Michel Geist has authored 19 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Genetics and 6 papers in Oncology. Recurrent topics in Michel Geist's work include Virus-based gene therapy research (10 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (4 papers). Michel Geist is often cited by papers focused on Virus-based gene therapy research (10 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (4 papers). Michel Geist collaborates with scholars based in France, Germany and Switzerland. Michel Geist's co-authors include Reinhard Pabst, H.‐J. Rothkötter, Karin Dott, Danièle Spehner, Marie Paule Kiény, J. P. Lecocq, B. Guy, Philippe Erbs, Jean‐Baptiste Marchand and Xavier Préville and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Virology.

In The Last Decade

Michel Geist

19 papers receiving 435 citations

Peers

Countries citing papers authored by Michel Geist

Since Specialization

Citations

This map shows the geographic impact of Michel Geist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Geist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Geist more than expected).

Fields of papers citing papers by Michel Geist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Geist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Geist. The network helps show where Michel Geist may publish in the future.

Co-authorship network of co-authors of Michel Geist

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Geist. A scholar is included among the top collaborators of Michel Geist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Geist. Michel Geist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laetitia Fend, (unknown), Michel Geist, (unknown), (unknown), Nathalie Silvestre, (unknown), Peter Fitzgerald, Éric Quéméneur, Jean‐Baptiste Marchand	1
2	Abstract 2352: Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allow their intratumoral delivery and an improved tumor-growth inhibition 2016 ·Cancer Research ·Jean‐Baptiste Marchand, (unknown), Laetitia Fend, Christine Thioudellet, Michel Geist, (unknown), (unknown), (unknown), Dominique Villeval, Karola Rittner, Nathalie Silvestre, Philippe Erbs, Laurence Zitvogel, Éric Quéméneur, Xavier Préville	1
3	Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition 2016 ·OncoImmunology ·(unknown), Laetitia Fend, Christine Thioudellet, Michel Geist, (unknown), (unknown), (unknown), D Schmitt, Murielle Gantzer, (unknown), (unknown), Dominique Villeval, Karola Rittner, Nathalie Silvestre, Philippe Erbs, Laurence Zitvogel, Éric Quéméneur, Xavier Préville, Jean‐Baptiste Marchand	84
4	O031 : TG1050, a novel immunotherapeutic to treat chronic hepatitis B, can control HBsAg and provoke HBsAg seroconversion in HBV-persistent mouse models 2015 ·Journal of Hepatology ·Karine Lélu, (unknown), Roland Kratzer, Sarah Dion, Maryline Bourgine, Ophélie Godon, D Schmitt, Christophe Dubois, (unknown), Y. Schlesinger, Jean‐Baptiste Marchand, Michel Geist, (unknown), Annie Findeli, (unknown), Nathalie Silvestre, Marie‐Laure Michel, Geneviève Inchauspé, P. J. Martin	1
5	Abstract 288: TG3003, an immunomodulatory anti-CD115 mAb targeting M2-macrophage polarization in the tumor microenvironment 2015 ·Cancer Research ·Hélène Haegel, (unknown), Luc Barraud, Jean‐Yves Bonnefoy, (unknown), Vanessa Duong, Michel Geist, (unknown), (unknown), Jean‐Baptiste Marchand, (unknown), Ronald Rooke, Christine Thioudellet, (unknown), Xavier Préville	2
6	3D modeling and characterization of the human CD115 monoclonal antibody H27K15 epitope and design of a chimeric CD115 target 2014 ·mAbs ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michel Geist, (unknown), (unknown), Hélène Haegel, (unknown), (unknown), Jean‐Yves Bonnefoy, Jean‐Baptiste Marchand, Philippe Ancian	8
7	Yeast Virus-Derived Stimulator of the Innate Immune System Augments the Efficacy of Virus Vector-Based Immunotherapy 2014 ·Journal of Virology ·(unknown), (unknown), (unknown), (unknown), Michel Geist, (unknown), (unknown), (unknown), (unknown), Anass Jawhari, (unknown), Jean‐Baptiste Marchand, Pascale Romby, Patrick Schultz, Gunther Hartmann, Ronald Rooke, Jean‐Yves Bonnefoy, Xavier Préville, Karola Rittner	14
8	A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells 2013 ·mAbs ·Hélène Haegel, Christine Thioudellet, (unknown), Michel Geist, (unknown), (unknown), Jean‐Baptiste Marchand, (unknown), Vanessa Duong, (unknown), (unknown), Xavier Préville, (unknown), (unknown), Philippe Ancian, Jukka P. Rissanen, Pascal Clayette, (unknown), Ronald Rooke, J Y Bonnefoy	32
9	The Immunogenicity of the Tumor-Associated Antigenα-Fetoprotein Is Enhanced by a Fusion with a Transmembrane Domain 2012 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Vanessa Gauttier, Michel Geist, (unknown), Ronald Rooke, Georges Vassaux, Sophie Conchon	5
10	Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy 2008 ·Cancer Gene Therapy ·(unknown), Michel Geist, Catherine Ledoux, (unknown), Stéphane Paul, Philippe Erbs, N. Corvaı̈a, Paul von Hoegen, (unknown), Hélène Haegel	13
11	Specific Tumor Cell Targeting by a Recombinant MVA Expressing a Functional Single Chain Antibody on the Surface of Intracellular Mature Virus (IMV) Particles 2007 ·Viral Immunology ·Stéphane Paul, Michel Geist, (unknown), David Snary, Joyce Taylor‐Papadimitriou, Bruce Acres, Nathalie Silvestre, Marie-Paule Kiény, Jean‐Marc Balloul	4
12	Modified vaccinia virus Ankara as a vector for suicide gene therapy 2007 ·Cancer Gene Therapy ·Philippe Erbs, Annie Findeli, Jacqueline Kintz, Pascale Cordier, Chantal Hoffmann, Michel Geist, (unknown)	39
13	Tumor gene therapy by MVA-mediated expression of T-cell–stimulating antibodies 2002 ·Cancer Gene Therapy ·Stéphane Paul, Etienne Régulier, Ronald Rooke, Fabienne Stoeckel, Michel Geist, Horst E. Homann, Jean‐Marc Balloul, Dominique Villeval, Yves Poitevin, Marie-Paule Kiény, R B Acres	19
14	Enveloped Virus Is the Major Virus Form Produced during Productive Infection with the Modified Vaccinia Virus Ankara Strain 2000 ·Virology ·Danièle Spehner, Robert Drillien, Fabienne Proamer, (unknown), (unknown), Michel Geist, Karin Dott, (unknown)	16
15	Targeted Macrophage Cytotoxicity Using a Nonreplicative Live Vector Expressing a Tumor-Specific Single-Chain Variable Region Fragment 2000 ·Human Gene Therapy ·Stéphane Paul, David Snary, Johan Hoebeke, Deborah Allen, Jean‐Marc Balloul, Nadine Bizouarne, (unknown), Michel Geist, J. Hilgers, Marie Paule Kiény, Joy Burchell, Joyce Taylor‐Papadimitriou, R B Acres	22
16	Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer. 1994 ·PubMed ·Jean‐Marc Balloul, R B Acres, Michel Geist, Karin Dott, Lenita M. Stefani, D Schmitt, Robert Drillien, Danièle Spehner, Ian F. C. McKenzie, Pei‐Xiang Xing	16
17	A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein 1991 ·Journal of Virology ·B. Guy, Michel Geist, Karin Dott, Danièle Spehner, Marie Paule Kiény, J. P. Lecocq	70
18	Age-Dependence of Lymphocyte Production in Peyer’s Patch Follicles in Contrast to the Other Peyer’s Patch Compartments and the Thymus 1988 ·Advances in experimental medicine and biology ·H.‐J. Rothkötter, Michel Geist, (unknown), Reinhard Pabst	1
19	Postnatal development and lymphocyte production of jejunal and ileal Peyer's patches in normal and gnotobiotic pigs. 1988 ·PubMed ·Reinhard Pabst, Michel Geist, H.‐J. Rothkötter, (unknown)	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact